Table 2.
Item | Control | Antibiotic 1 | Essential oil | SEM | P |
---|---|---|---|---|---|
Phase 1 (d 0 to 7) | |||||
Weight gain, g/d | 354 | 378 | 416 | 28 | 0.33 |
Feed intake, g/d | 473 | 478 | 502 | 26 | 0.71 |
Feed conversion | 1.36 | 1.3 | 1.24 | 0.08 | 0.59 |
Phase 2 (d 8 to 35) | |||||
Weight gain, g/d | 465b | 539a | 513a | 15 | <0.01 |
Feed intake, g/d | 860 | 937 | 861 | 26 | 0.07 |
Feed conversion | 1.87 | 1.73 | 1.69 | 0.07 | 0.18 |
Overall (d 0 to 35) | |||||
Weight gain, g/d | 442b | 505a | 493a | 15 | 0.02 |
Feed intake, g/d | 783 | 846 | 789 | 24 | 0.13 |
Feed conversion | 1.79 | 1.67 | 1.62 | 0.06 | 0.20 |
Feed consistency | 1.53b | 1.22a | 1.30a | 0.06 | 0.02 |
Li et al. [19].
1Control = Basal diet; Antibiotic = Basal diet supplemented with 150 mg/kg chlortetracycline, 80 mg/kg colistin sulfate, and 50 mg/kg kitasamycin); EO = Basal diet supplemented with 18 mg/kg of thymol and cinnamaldehyde.
a-bMeans in the same row with different superscripts are significantly different (P < 0.05).